These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16930355)

  • 21. [Mitochondrial beta-oxidation defects].
    Woldseth B; Rootwelt T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):756-9. PubMed ID: 16541168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of energy metabolism by long-chain fatty acids.
    Nakamura MT; Yudell BE; Loor JJ
    Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of FAT/CD36 to the regulation of skeletal muscle fatty acid oxidation: an overview.
    Holloway GP; Luiken JJ; Glatz JF; Spriet LL; Bonen A
    Acta Physiol (Oxf); 2008 Dec; 194(4):293-309. PubMed ID: 18510711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation].
    Angelini C
    Acta Neurol (Napoli); 1989 Oct; 11(5):330-4. PubMed ID: 2603779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EFNS guidelines on management of neurological problems in liver transplantation.
    Guarino M; Benito-Leon J; Decruyenaere J; Schmutzhard E; Weissenborn K; Stracciari A;
    Eur J Neurol; 2006 Jan; 13(1):2-9. PubMed ID: 16420387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New therapeutic approaches in mitochondrial fatty acid oxidation disorders].
    Labarthe F
    Arch Pediatr; 2008 Jun; 15(5):608-10. PubMed ID: 18582688
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-chain fatty acid oxidation during early human development.
    Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
    Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carnitine deficiency in chronic critical illness.
    Bonafé L; Berger MM; Que YA; Mechanick JI
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):200-9. PubMed ID: 24500444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EFNS guidelines on cognitive rehabilitation: report of an EFNS task force.
    Cappa SF; Benke T; Clarke S; Rossi B; Stemmer B; van Heugten CM;
    Eur J Neurol; 2003 Jan; 10(1):11-23. PubMed ID: 12534988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic disorders of carnitine metabolism and their nutritional management.
    Kerner J; Hoppel C
    Annu Rev Nutr; 1998; 18():179-206. PubMed ID: 9706223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.
    Dessein AF; Fontaine M; Dobbelaere D; Mention-Mulliez K; Martin-Ponthieu A; Briand G; Vamecq J
    Clin Chim Acta; 2009 Aug; 406(1-2):23-6. PubMed ID: 19422814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid oxidation defects as a cause of neuromyopathic disease in infants and adults.
    Olpin SE
    Clin Lab; 2005; 51(5-6):289-306. PubMed ID: 15991803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carnitine palmityl transferase I deficiency.
    Al-Aqeel AI; Rashed MS; Ruiter JP; Al-Husseini HF; Al-Amoudi MS; Wanders RJ
    Saudi Med J; 2001 Nov; 22(11):1025-9. PubMed ID: 11744980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
    Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
    Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.
    Deisenhammer F; Bartos A; Egg R; Gilhus NE; Giovannoni G; Rauer S; Sellebjerg F;
    Eur J Neurol; 2006 Sep; 13(9):913-22. PubMed ID: 16930354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches.
    Rector RS; Payne RM; Ibdah JA
    Adv Drug Deliv Rev; 2008; 60(13-14):1488-96. PubMed ID: 18652860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Federation of Neurological Societies (EFNS) guideline papers.
    Olesen J
    Eur J Neurol; 1999 May; 6(3):257-8. PubMed ID: 10210903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.